Share Price and Basic Stock Data
Last Updated: November 22, 2025, 9:48 am
| PEG Ratio | 0.39 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Sicagen India Ltd operates in the Trading & Distributors industry, with a current share price of ₹61.7 and a market capitalization of ₹244 Cr. The company reported sales of ₹895 Cr for the fiscal year ending March 2023, showing a recovery from ₹836 Cr in FY 2022. However, sales are projected to decline to ₹795 Cr in FY 2024 before rebounding to ₹892 Cr in FY 2025. Quarterly sales have exhibited variability, with the highest quarterly sales recorded at ₹258.19 Cr in December 2022, while the latest quarter ending June 2023 saw sales of ₹166.43 Cr. This fluctuation highlights the company’s sensitivity to market conditions and operational challenges. The operating profit margin (OPM) stood at 4.76% for FY 2025, indicating a gradual improvement from the previous year’s 3% OPM in FY 2022. The company’s ability to maintain sales growth amidst fluctuating quarterly performances suggests a need for strategic initiatives to stabilize revenue streams.
Profitability and Efficiency Metrics
Sicagen India Ltd’s profitability metrics reflect a mixed performance. The net profit for FY 2023 was reported at ₹17 Cr, up from a loss of ₹1 Cr in FY 2022, showcasing a significant turnaround. The earnings per share (EPS) for FY 2025 stood at ₹4.32, increasing from ₹4.50 in FY 2023. The operating profit margin has fluctuated, with a recorded high of 5% in March 2023, but settling at 4.76% in FY 2025. Efficiency metrics indicate that the cash conversion cycle (CCC) is at 134 days, which is relatively high compared to industry standards, suggesting potential inefficiencies in inventory management or receivables collection. The interest coverage ratio (ICR) of 3.95x indicates that the company is comfortably covering its interest expenses, reflecting a manageable debt load. However, the return on equity (ROE) remains low at 3.41%, indicative of underutilization of equity capital, which could deter potential investors.
Balance Sheet Strength and Financial Ratios
Sicagen’s balance sheet reflects a cautious approach to leverage, with total borrowings reported at ₹164 Cr against total reserves of ₹478 Cr. The debt-to-equity ratio stands at 0.27, indicating a low level of financial risk. The current ratio is robust at 2.29, suggesting the company is well-positioned to meet short-term obligations. Additionally, the company’s book value per share has increased to ₹122.31 in FY 2025, up from ₹116.19 in FY 2024, reflecting a strengthening equity base. However, the price-to-book value (P/BV) ratio of 0.50x indicates that the stock is trading at a discount compared to its book value, suggesting potential undervaluation. The return on capital employed (ROCE) is reported at 5.57%, which, while improving, is still below industry benchmarks, indicating that capital is not being utilized as effectively as it could be. Such metrics highlight the need for improved operational efficiency to enhance shareholder value.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Sicagen India Ltd indicates a strong promoter commitment, with promoters holding 61.13% of the shares as of September 2025. This is a significant increase from 45.66% in December 2022, reflecting a consolidation of control. Foreign institutional investors (FIIs) hold a modest 2.42% stake, down from 7.34%, which may raise concerns about foreign investor confidence. Domestic institutional investors (DIIs) hold 0.58%, a stable but low figure, indicating limited institutional interest. The public shareholding stands at 35.88%, down from 46.38% in December 2022, suggesting a gradual exit of retail investors. The total number of shareholders has also declined from 25,689 in December 2022 to 23,326, signaling potential disenchantment among smaller investors. The concentration of ownership could lead to volatility in stock performance, especially in response to any adverse news or market conditions.
Outlook, Risks, and Final Insight
Looking ahead, Sicagen India Ltd faces both opportunities and challenges. The company has shown resilience in improving its profitability metrics, yet it remains vulnerable to market fluctuations as evidenced by its inconsistent quarterly sales. The high cash conversion cycle presents a risk to liquidity, necessitating a focus on operational efficiency. Moreover, the declining interest from institutional investors could hinder future capital raising efforts. However, the strong promoter backing and low debt levels provide a solid foundation for potential growth. The company’s ability to enhance its operational efficiency and stabilize revenue streams will be crucial in maintaining investor confidence. In scenarios where operational improvements are successfully implemented, Sicagen could see enhanced profitability and a healthier market perception. Conversely, failure to address these operational inefficiencies could result in stagnant growth and further erosion of investor confidence.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Sicagen India Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minal Industries Ltd | 67.9 Cr. | 3.54 | 5.59/3.20 | 45.3 | 2.78 | 0.00 % | 5.97 % | 2.83 % | 2.00 |
| Modella Woollens Ltd | 6.69 Cr. | 73.5 | 74.8/52.5 | 4.95 | 0.00 % | % | % | 10.0 | |
| MRC Agrotech Ltd | 104 Cr. | 50.6 | 50.7/10.2 | 115 | 15.1 | 0.00 % | 5.89 % | 4.46 % | 10.0 |
| MRP Agro Ltd | 107 Cr. | 96.0 | 174/84.4 | 15.1 | 30.6 | 0.00 % | 39.2 % | 30.3 % | 10.0 |
| Muller and Phipps (India) Ltd | 14.0 Cr. | 225 | 559/208 | 176 | 22.9 | 0.00 % | % | % | 10.0 |
| Industry Average | 12,184.29 Cr | 164.18 | 88.86 | 122.48 | 0.39% | 15.57% | 8.99% | 7.71 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 163.87 | 245.82 | 258.19 | 227.42 | 166.43 | 180.08 | 227.70 | 221.23 | 232.26 | 197.71 | 210.26 | 251.65 | 204.54 |
| Expenses | 158.96 | 242.46 | 251.32 | 216.05 | 157.99 | 174.97 | 222.48 | 212.85 | 222.99 | 189.44 | 203.04 | 240.91 | 194.80 |
| Operating Profit | 4.91 | 3.36 | 6.87 | 11.37 | 8.44 | 5.11 | 5.22 | 8.38 | 9.27 | 8.27 | 7.22 | 10.74 | 9.74 |
| OPM % | 3.00% | 1.37% | 2.66% | 5.00% | 5.07% | 2.84% | 2.29% | 3.79% | 3.99% | 4.18% | 3.43% | 4.27% | 4.76% |
| Other Income | 2.18 | 2.95 | 1.87 | 7.55 | 1.32 | 1.49 | 2.85 | 1.44 | 2.03 | 2.72 | 3.18 | 2.27 | 1.92 |
| Interest | 1.91 | 2.05 | 2.28 | 2.64 | 2.59 | 2.47 | 2.65 | 2.94 | 2.62 | 2.83 | 2.50 | 3.07 | 3.04 |
| Depreciation | 2.08 | 2.78 | 2.13 | 3.55 | 2.12 | 2.12 | 2.19 | 3.33 | 2.29 | 2.31 | 2.39 | 3.51 | 2.39 |
| Profit before tax | 3.10 | 1.48 | 4.33 | 12.73 | 5.05 | 2.01 | 3.23 | 3.55 | 6.39 | 5.85 | 5.51 | 6.43 | 6.23 |
| Tax % | 26.77% | 37.16% | 20.32% | 12.25% | 24.75% | 35.32% | 28.17% | 12.68% | 24.88% | 29.23% | 23.77% | 38.26% | 27.13% |
| Net Profit | 2.27 | 0.93 | 3.45 | 11.17 | 3.80 | 1.30 | 2.32 | 3.10 | 4.80 | 4.14 | 4.20 | 3.97 | 4.54 |
| EPS in Rs | 0.57 | 0.24 | 0.87 | 2.82 | 0.96 | 0.33 | 0.59 | 0.78 | 1.21 | 1.05 | 1.06 | 1.00 | 1.15 |
Last Updated: August 20, 2025, 3:35 am
Below is a detailed analysis of the quarterly data for Sicagen India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 204.54 Cr.. The value appears to be declining and may need further review. It has decreased from 251.65 Cr. (Mar 2025) to 204.54 Cr., marking a decrease of 47.11 Cr..
- For Expenses, as of Jun 2025, the value is 194.80 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 240.91 Cr. (Mar 2025) to 194.80 Cr., marking a decrease of 46.11 Cr..
- For Operating Profit, as of Jun 2025, the value is 9.74 Cr.. The value appears to be declining and may need further review. It has decreased from 10.74 Cr. (Mar 2025) to 9.74 Cr., marking a decrease of 1.00 Cr..
- For OPM %, as of Jun 2025, the value is 4.76%. The value appears strong and on an upward trend. It has increased from 4.27% (Mar 2025) to 4.76%, marking an increase of 0.49%.
- For Other Income, as of Jun 2025, the value is 1.92 Cr.. The value appears to be declining and may need further review. It has decreased from 2.27 Cr. (Mar 2025) to 1.92 Cr., marking a decrease of 0.35 Cr..
- For Interest, as of Jun 2025, the value is 3.04 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.07 Cr. (Mar 2025) to 3.04 Cr., marking a decrease of 0.03 Cr..
- For Depreciation, as of Jun 2025, the value is 2.39 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.51 Cr. (Mar 2025) to 2.39 Cr., marking a decrease of 1.12 Cr..
- For Profit before tax, as of Jun 2025, the value is 6.23 Cr.. The value appears to be declining and may need further review. It has decreased from 6.43 Cr. (Mar 2025) to 6.23 Cr., marking a decrease of 0.20 Cr..
- For Tax %, as of Jun 2025, the value is 27.13%. The value appears to be improving (decreasing) as expected. It has decreased from 38.26% (Mar 2025) to 27.13%, marking a decrease of 11.13%.
- For Net Profit, as of Jun 2025, the value is 4.54 Cr.. The value appears strong and on an upward trend. It has increased from 3.97 Cr. (Mar 2025) to 4.54 Cr., marking an increase of 0.57 Cr..
- For EPS in Rs, as of Jun 2025, the value is 1.15. The value appears strong and on an upward trend. It has increased from 1.00 (Mar 2025) to 1.15, marking an increase of 0.15.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 4:27 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 620 | 645 | 601 | 711 | 738 | 820 | 699 | 542 | 836 | 895 | 795 | 892 | 893 |
| Expenses | 631 | 644 | 608 | 707 | 737 | 817 | 688 | 533 | 814 | 869 | 768 | 856 | 856 |
| Operating Profit | -11 | 1 | -7 | 3 | 1 | 3 | 11 | 9 | 22 | 27 | 28 | 36 | 37 |
| OPM % | -2% | 0% | -1% | 0% | 0% | 0% | 2% | 2% | 3% | 3% | 3% | 4% | 4% |
| Other Income | 41 | 18 | 18 | 15 | 15 | 15 | 11 | 8 | -0 | 15 | 7 | 9 | 9 |
| Interest | 7 | 6 | 6 | 7 | 9 | 9 | 9 | 5 | 6 | 9 | 11 | 11 | 11 |
| Depreciation | 6 | 5 | 5 | 4 | 5 | 6 | 10 | 10 | 11 | 11 | 10 | 10 | 11 |
| Profit before tax | 17 | 8 | -1 | 8 | 2 | 3 | 3 | 1 | 5 | 22 | 14 | 24 | 24 |
| Tax % | 1% | 13% | -300% | 3% | 30% | 95% | 89% | 322% | 112% | 18% | 24% | 29% | |
| Net Profit | 17 | 7 | 1 | 7 | 1 | 0 | 0 | -3 | -1 | 18 | 11 | 17 | 17 |
| EPS in Rs | 4.27 | 1.67 | 0.27 | 1.89 | 0.29 | 0.03 | 0.09 | -0.81 | -0.15 | 4.50 | 2.66 | 4.32 | 4.26 |
| Dividend Payout % | 19% | 36% | 224% | 32% | 206% | 1,218% | 550% | -74% | -162% | 13% | 23% | 23% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -58.82% | -85.71% | 600.00% | -85.71% | -100.00% | 66.67% | 1900.00% | -38.89% | 54.55% |
| Change in YoY Net Profit Growth (%) | 0.00% | -26.89% | 685.71% | -685.71% | -14.29% | 166.67% | 1833.33% | -1938.89% | 93.43% |
Sicagen India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 5% |
| 3 Years: | 2% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 113% |
| 3 Years: | 136% |
| TTM: | 32% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 45% |
| 3 Years: | 27% |
| 1 Year: | -30% |
| Return on Equity | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 2% |
| 3 Years: | 3% |
| Last Year: | 3% |
Last Updated: September 5, 2025, 1:31 pm
Balance Sheet
Last Updated: November 9, 2025, 2:56 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 |
| Reserves | 441 | 439 | 443 | 345 | 353 | 343 | 336 | 355 | 383 | 400 | 420 | 444 | 478 |
| Borrowings | 73 | 48 | 60 | 89 | 97 | 119 | 96 | 79 | 95 | 121 | 121 | 148 | 164 |
| Other Liabilities | 119 | 84 | 76 | 105 | 114 | 184 | 133 | 72 | 140 | 68 | 143 | 90 | 148 |
| Total Liabilities | 673 | 610 | 619 | 578 | 604 | 685 | 605 | 546 | 656 | 629 | 723 | 722 | 830 |
| Fixed Assets | 64 | 59 | 57 | 183 | 203 | 151 | 168 | 168 | 141 | 141 | 140 | 137 | 140 |
| CWIP | 0 | 1 | 2 | 12 | 0 | 0 | 1 | 0 | -0 | 0 | 1 | -0 | 1 |
| Investments | 100 | 100 | 100 | 54 | 34 | 26 | 20 | 37 | 70 | 69 | 73 | 79 | 93 |
| Other Assets | 509 | 451 | 460 | 329 | 367 | 507 | 417 | 340 | 445 | 418 | 510 | 505 | 596 |
| Total Assets | 673 | 610 | 619 | 578 | 604 | 685 | 605 | 546 | 656 | 629 | 723 | 722 | 830 |
Below is a detailed analysis of the balance sheet data for Sicagen India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 40.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 40.00 Cr..
- For Reserves, as of Sep 2025, the value is 478.00 Cr.. The value appears strong and on an upward trend. It has increased from 444.00 Cr. (Mar 2025) to 478.00 Cr., marking an increase of 34.00 Cr..
- For Borrowings, as of Sep 2025, the value is 164.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 148.00 Cr. (Mar 2025) to 164.00 Cr., marking an increase of 16.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 148.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 90.00 Cr. (Mar 2025) to 148.00 Cr., marking an increase of 58.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 830.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 722.00 Cr. (Mar 2025) to 830.00 Cr., marking an increase of 108.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 140.00 Cr.. The value appears strong and on an upward trend. It has increased from 137.00 Cr. (Mar 2025) to 140.00 Cr., marking an increase of 3.00 Cr..
- For CWIP, as of Sep 2025, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 1.00 Cr., marking an increase of 1.00 Cr..
- For Investments, as of Sep 2025, the value is 93.00 Cr.. The value appears strong and on an upward trend. It has increased from 79.00 Cr. (Mar 2025) to 93.00 Cr., marking an increase of 14.00 Cr..
- For Other Assets, as of Sep 2025, the value is 596.00 Cr.. The value appears strong and on an upward trend. It has increased from 505.00 Cr. (Mar 2025) to 596.00 Cr., marking an increase of 91.00 Cr..
- For Total Assets, as of Sep 2025, the value is 830.00 Cr.. The value appears strong and on an upward trend. It has increased from 722.00 Cr. (Mar 2025) to 830.00 Cr., marking an increase of 108.00 Cr..
Notably, the Reserves (478.00 Cr.) exceed the Borrowings (164.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -84.00 | -47.00 | -67.00 | -86.00 | -96.00 | -116.00 | -85.00 | -70.00 | -73.00 | -94.00 | -93.00 | -112.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 75 | 61 | 71 | 75 | 91 | 119 | 108 | 115 | 107 | 76 | 114 | 94 |
| Inventory Days | 70 | 56 | 59 | 70 | 68 | 58 | 78 | 80 | 50 | 65 | 67 | 60 |
| Days Payable | 35 | 19 | 19 | 32 | 42 | 75 | 60 | 40 | 60 | 24 | 47 | 20 |
| Cash Conversion Cycle | 110 | 98 | 110 | 113 | 117 | 102 | 126 | 155 | 97 | 117 | 134 | 134 |
| Working Capital Days | 67 | 69 | 78 | 67 | 73 | 61 | 99 | 114 | 84 | 85 | 97 | 88 |
| ROCE % | 2% | 2% | 1% | 3% | 2% | 3% | 3% | 2% | 4% | 4% | 4% | 5% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 4.32 | 2.65 | 4.50 | -0.15 | -0.81 |
| Diluted EPS (Rs.) | 4.32 | 2.65 | 4.50 | -0.15 | -0.81 |
| Cash EPS (Rs.) | 6.98 | 5.12 | 7.17 | 2.61 | 1.70 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 122.31 | 116.19 | 111.08 | 106.73 | 99.75 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 122.31 | 116.19 | 111.08 | 106.73 | 99.75 |
| Revenue From Operations / Share (Rs.) | 225.39 | 201.02 | 226.26 | 211.31 | 136.88 |
| PBDIT / Share (Rs.) | 11.01 | 8.66 | 8.77 | 7.72 | 4.25 |
| PBIT / Share (Rs.) | 8.35 | 6.19 | 6.11 | 4.96 | 1.74 |
| PBT / Share (Rs.) | 6.11 | 3.50 | 5.47 | 1.27 | 0.36 |
| Net Profit / Share (Rs.) | 4.32 | 2.65 | 4.50 | -0.15 | -0.80 |
| NP After MI And SOA / Share (Rs.) | 4.32 | 2.65 | 4.50 | -0.15 | -0.80 |
| PBDIT Margin (%) | 4.88 | 4.30 | 3.87 | 3.65 | 3.10 |
| PBIT Margin (%) | 3.70 | 3.07 | 2.69 | 2.34 | 1.27 |
| PBT Margin (%) | 2.71 | 1.73 | 2.41 | 0.59 | 0.26 |
| Net Profit Margin (%) | 1.91 | 1.31 | 1.99 | -0.07 | -0.59 |
| NP After MI And SOA Margin (%) | 1.91 | 1.31 | 1.99 | -0.07 | -0.59 |
| Return on Networth / Equity (%) | 3.53 | 2.28 | 4.05 | -0.14 | -0.81 |
| Return on Capital Employeed (%) | 6.58 | 5.12 | 5.29 | 4.47 | 1.60 |
| Return On Assets (%) | 2.37 | 1.50 | 2.83 | -0.09 | -0.56 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Total Debt / Equity (X) | 0.27 | 0.22 | 0.24 | 0.18 | 0.16 |
| Asset Turnover Ratio (%) | 1.26 | 1.20 | 1.39 | 0.85 | 0.66 |
| Current Ratio (X) | 2.29 | 2.17 | 2.38 | 2.01 | 2.57 |
| Quick Ratio (X) | 1.70 | 1.58 | 1.55 | 1.54 | 1.76 |
| Inventory Turnover Ratio (X) | 2.64 | 2.28 | 3.78 | 0.70 | 0.48 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 22.59 | 5.55 | -388.52 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 11.69 | 3.49 | 22.96 | 0.00 |
| Earning Retention Ratio (%) | 0.00 | 77.41 | 94.45 | 488.52 | 0.00 |
| Cash Earning Retention Ratio (%) | 0.00 | 88.31 | 96.51 | 77.04 | 0.00 |
| Interest Coverage Ratio (X) | 3.95 | 3.22 | 3.91 | 5.18 | 3.08 |
| Interest Coverage Ratio (Post Tax) (X) | 2.36 | 1.98 | 2.29 | 2.37 | 0.41 |
| Enterprise Value (Cr.) | 307.23 | 291.78 | 198.21 | 139.51 | 85.90 |
| EV / Net Operating Revenue (X) | 0.34 | 0.36 | 0.22 | 0.16 | 0.15 |
| EV / EBITDA (X) | 7.05 | 8.52 | 5.71 | 4.57 | 5.10 |
| MarketCap / Net Operating Revenue (X) | 0.27 | 0.29 | 0.13 | 0.10 | 0.10 |
| Retention Ratios (%) | 0.00 | 77.40 | 94.44 | 488.52 | 0.00 |
| Price / BV (X) | 0.50 | 0.50 | 0.27 | 0.20 | 0.14 |
| Price / Net Operating Revenue (X) | 0.27 | 0.29 | 0.13 | 0.10 | 0.10 |
| EarningsYield | 0.07 | 0.04 | 0.14 | -0.01 | -0.05 |
After reviewing the key financial ratios for Sicagen India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 4.32. This value is below the healthy minimum of 5. It has increased from 2.65 (Mar 24) to 4.32, marking an increase of 1.67.
- For Diluted EPS (Rs.), as of Mar 25, the value is 4.32. This value is below the healthy minimum of 5. It has increased from 2.65 (Mar 24) to 4.32, marking an increase of 1.67.
- For Cash EPS (Rs.), as of Mar 25, the value is 6.98. This value is within the healthy range. It has increased from 5.12 (Mar 24) to 6.98, marking an increase of 1.86.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 122.31. It has increased from 116.19 (Mar 24) to 122.31, marking an increase of 6.12.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 122.31. It has increased from 116.19 (Mar 24) to 122.31, marking an increase of 6.12.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 225.39. It has increased from 201.02 (Mar 24) to 225.39, marking an increase of 24.37.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 11.01. This value is within the healthy range. It has increased from 8.66 (Mar 24) to 11.01, marking an increase of 2.35.
- For PBIT / Share (Rs.), as of Mar 25, the value is 8.35. This value is within the healthy range. It has increased from 6.19 (Mar 24) to 8.35, marking an increase of 2.16.
- For PBT / Share (Rs.), as of Mar 25, the value is 6.11. This value is within the healthy range. It has increased from 3.50 (Mar 24) to 6.11, marking an increase of 2.61.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 4.32. This value is within the healthy range. It has increased from 2.65 (Mar 24) to 4.32, marking an increase of 1.67.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 4.32. This value is within the healthy range. It has increased from 2.65 (Mar 24) to 4.32, marking an increase of 1.67.
- For PBDIT Margin (%), as of Mar 25, the value is 4.88. This value is below the healthy minimum of 10. It has increased from 4.30 (Mar 24) to 4.88, marking an increase of 0.58.
- For PBIT Margin (%), as of Mar 25, the value is 3.70. This value is below the healthy minimum of 10. It has increased from 3.07 (Mar 24) to 3.70, marking an increase of 0.63.
- For PBT Margin (%), as of Mar 25, the value is 2.71. This value is below the healthy minimum of 10. It has increased from 1.73 (Mar 24) to 2.71, marking an increase of 0.98.
- For Net Profit Margin (%), as of Mar 25, the value is 1.91. This value is below the healthy minimum of 5. It has increased from 1.31 (Mar 24) to 1.91, marking an increase of 0.60.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.91. This value is below the healthy minimum of 8. It has increased from 1.31 (Mar 24) to 1.91, marking an increase of 0.60.
- For Return on Networth / Equity (%), as of Mar 25, the value is 3.53. This value is below the healthy minimum of 15. It has increased from 2.28 (Mar 24) to 3.53, marking an increase of 1.25.
- For Return on Capital Employeed (%), as of Mar 25, the value is 6.58. This value is below the healthy minimum of 10. It has increased from 5.12 (Mar 24) to 6.58, marking an increase of 1.46.
- For Return On Assets (%), as of Mar 25, the value is 2.37. This value is below the healthy minimum of 5. It has increased from 1.50 (Mar 24) to 2.37, marking an increase of 0.87.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.27. This value is within the healthy range. It has increased from 0.22 (Mar 24) to 0.27, marking an increase of 0.05.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.26. It has increased from 1.20 (Mar 24) to 1.26, marking an increase of 0.06.
- For Current Ratio (X), as of Mar 25, the value is 2.29. This value is within the healthy range. It has increased from 2.17 (Mar 24) to 2.29, marking an increase of 0.12.
- For Quick Ratio (X), as of Mar 25, the value is 1.70. This value is within the healthy range. It has increased from 1.58 (Mar 24) to 1.70, marking an increase of 0.12.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.64. This value is below the healthy minimum of 4. It has increased from 2.28 (Mar 24) to 2.64, marking an increase of 0.36.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 22.59 (Mar 24) to 0.00, marking a decrease of 22.59.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 11.69 (Mar 24) to 0.00, marking a decrease of 11.69.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 77.41 (Mar 24) to 0.00, marking a decrease of 77.41.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 88.31 (Mar 24) to 0.00, marking a decrease of 88.31.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 3.95. This value is within the healthy range. It has increased from 3.22 (Mar 24) to 3.95, marking an increase of 0.73.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.36. This value is below the healthy minimum of 3. It has increased from 1.98 (Mar 24) to 2.36, marking an increase of 0.38.
- For Enterprise Value (Cr.), as of Mar 25, the value is 307.23. It has increased from 291.78 (Mar 24) to 307.23, marking an increase of 15.45.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.34. This value is below the healthy minimum of 1. It has decreased from 0.36 (Mar 24) to 0.34, marking a decrease of 0.02.
- For EV / EBITDA (X), as of Mar 25, the value is 7.05. This value is within the healthy range. It has decreased from 8.52 (Mar 24) to 7.05, marking a decrease of 1.47.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1. It has decreased from 0.29 (Mar 24) to 0.27, marking a decrease of 0.02.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 77.40 (Mar 24) to 0.00, marking a decrease of 77.40.
- For Price / BV (X), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.50.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1. It has decreased from 0.29 (Mar 24) to 0.27, marking a decrease of 0.02.
- For EarningsYield, as of Mar 25, the value is 0.07. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.07, marking an increase of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Sicagen India Ltd:
- Net Profit Margin: 1.91%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 6.58% (Industry Average ROCE: 15.57%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 3.53% (Industry Average ROE: 8.99%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.36
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.7
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 15.6 (Industry average Stock P/E: 88.86)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.27
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.91%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Trading & Distributors | 4th Floor, SPIC House, No.88, Mount Road, Chennai (Madras) Tamil Nadu 600032 | info@sicagen.com http://www.sicagen.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ashwin C Muthiah | Chairman |
| Mr. Nandakumar Varma | Whole Time Director |
| Mr. R Chandrasekar | Director |
| Mr. Devaki Ashwin Muthiah | Director |
| Ms. Govindarajan Dattatreyan Sharma | Independent Director |
| Ms. Rita Chandrasekar | Independent Director |
| Mr. S Radhakrishnan | Independent Director |
| Mr. Batchu Sai Purshotham | Independent Director |
FAQ
What is the intrinsic value of Sicagen India Ltd?
Sicagen India Ltd's intrinsic value (as of 22 November 2025) is 56.67 which is 5.86% lower the current market price of 60.20, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 238 Cr. market cap, FY2025-2026 high/low of 96.9/54.0, reserves of ₹478 Cr, and liabilities of 830 Cr.
What is the Market Cap of Sicagen India Ltd?
The Market Cap of Sicagen India Ltd is 238 Cr..
What is the current Stock Price of Sicagen India Ltd as on 22 November 2025?
The current stock price of Sicagen India Ltd as on 22 November 2025 is 60.2.
What is the High / Low of Sicagen India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Sicagen India Ltd stocks is 96.9/54.0.
What is the Stock P/E of Sicagen India Ltd?
The Stock P/E of Sicagen India Ltd is 15.6.
What is the Book Value of Sicagen India Ltd?
The Book Value of Sicagen India Ltd is 131.
What is the Dividend Yield of Sicagen India Ltd?
The Dividend Yield of Sicagen India Ltd is 1.66 %.
What is the ROCE of Sicagen India Ltd?
The ROCE of Sicagen India Ltd is 5.57 %.
What is the ROE of Sicagen India Ltd?
The ROE of Sicagen India Ltd is 3.41 %.
What is the Face Value of Sicagen India Ltd?
The Face Value of Sicagen India Ltd is 10.0.